Debt-to-equity of OCULAR THERAPEUTIX, INC from 31 Mar 2015 to 31 Dec 2025

Taxonomy & unit
ratio: %
Description
Debt-to-equity (D/E) ratio is used to evaluate a company's financial leverage and is calculated by dividing a company's total liabilities by its shareholder equity.
Summary
OCULAR THERAPEUTIX, INC quarterly Debt-to-equity in % history and change rate from 31 Mar 2015 to 31 Dec 2025.
  • OCULAR THERAPEUTIX, INC Debt-to-equity for the quarter ending 31 Dec 2025 was 40%, a 5.1% increase year-over-year.
Debt-to-equity, Quarterly (%)
Debt-to-equity, YoY Quarterly Change (%)

OCULAR THERAPEUTIX, INC Quarterly Debt-to-equity (%)

Period Value YoY Chg Change % Date
Q4 2025 40% +1.9% +5.1% 31 Dec 2025
Q3 2025 51% +4.3% +9.4% 30 Sep 2025
Q2 2025 46% -21% -31% 30 Jun 2025
Q1 2025 43% -68% -61% 31 Mar 2025
Q4 2024 38% -457% -92% 31 Dec 2024
Q3 2024 46% -858% -95% 30 Sep 2024
Q2 2024 66% -426% -87% 30 Jun 2024
Q1 2024 111% -177% -61% 31 Mar 2024
Q4 2023 495% +301% +155% 31 Dec 2023
Q3 2023 904% +746% +470% 30 Sep 2023
Q2 2023 492% +348% +242% 30 Jun 2023
Q1 2023 288% +137% +91% 31 Mar 2023
Q4 2022 194% +30% +18% 31 Dec 2022
Q3 2022 159% -33% -17% 30 Sep 2022
Q2 2022 144% -110% -43% 30 Jun 2022
Q1 2022 151% -191% -56% 31 Mar 2022
Q4 2021 164% -546% -77% 31 Dec 2021
Q3 2021 191% +3023% 30 Sep 2021
Q2 2021 254% -14399% -98% 30 Jun 2021
Q1 2021 342% -5821% -94% 31 Mar 2021
Q4 2020 710% -52% -6.8% 31 Dec 2020
Q3 2020 -2832% -3167% -944% 30 Sep 2020
Q2 2020 14652% +14462% +7605% 30 Jun 2020
Q1 2020 6163% +6056% +5694% 31 Mar 2020
Q4 2019 763% +698% +1078% 31 Dec 2019
Q3 2019 335% +272% +426% 30 Sep 2019
Q2 2019 190% +120% +171% 30 Jun 2019
Q1 2019 106% +33% +45% 31 Mar 2019
Q4 2018 65% -2% -3% 31 Dec 2018
Q3 2018 64% +8.8% +16% 30 Sep 2018
Q2 2018 70% +25% +56% 30 Jun 2018
Q1 2018 73% +38% +105% 31 Mar 2018
Q4 2017 67% +36% +114% 31 Dec 2017
Q3 2017 55% +28% +107% 30 Sep 2017
Q2 2017 45% +21% +88% 30 Jun 2017
Q1 2017 36% +14% +66% 31 Mar 2017
Q4 2016 31% +8% +35% 31 Dec 2016
Q3 2016 27% +1.6% +6.3% 30 Sep 2016
Q2 2016 24% -3.3% -12% 30 Jun 2016
Q1 2016 22% -50% -70% 31 Mar 2016
Q4 2015 23% 31 Dec 2015
Q3 2015 25% 30 Sep 2015
Q2 2015 27% 30 Jun 2015
Q1 2015 71% 31 Mar 2015
* An asterisk sign (*) next to the value indicates that the value is likely invalid.